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E-mail address: kamitori@med.kagawa-u.ac.jp (S.Clostridium botulinum produces the botulinum neurotoxin, forming a large complex as progenitor
toxins in association with non-toxic non-hemagglutinin and/or several different hemagglutinin
(HA) subcomponents, HA33, HA17 and HA70, which bind to carbohydrate of glycoproteins from epi-
thelial cells in the infection process. To elucidate the carbohydrate recognition mechanism of HA70,
X-ray structures of HA70 from type C toxin (HA70/C) in complexes with sialylated oligosaccharides
were determined, and a binding assay by the glycoconjugate microarray was performed. These
results suggested that HA70/C can recognize both a2–3- and a2–6-sialylated oligosaccharides, and
that it has a higher afﬁnity for a2–3-sialylated oligosaccharides.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Clostridium botulinum produces the botulinum neurotoxin
(NTX) which is one of the most potent toxins, causing the disease
botulism. The NTX exists as seven different serotypes A through
G [1], and most NTXs form large complexes as progenitor toxins
(PTXs) in association with non-toxic non-hemagglutinin (NTNHA)
and/or several different hemagglutinin (HA) subcomponents. Type
A–D and G toxins produce PTXs consisting of one NTX, one NTNHA,
and three HA subcomponents, designated HA70 (also known as
HA3), HA33 (HA1), and HA17 (HA2) based on molecular mass
[2]. HA70 (HA3) is further proteolytically cleaved to HA22–23
(HA3a) and HA53 (HA3b) fragments [3,4]. Hasegawa et al. pro-
posed a hypothetical 14-mer model of the type D PTX based on
the X-ray structure of the HA33-HA17 (2:1) complex and electron
microscopy [5]. This model is composed of (6:3:3:1:1) of HA33,chemical Societies. Published by E
, progenitor toxin; NTNHA,
3SiaLac, a2-3-sialyllactose;
6-sialyllactose; 6SiaLacNAc,
cid moiety; Gal, galactose
y
Kamitori).HA17, HA70, NTNHA and NTX, with a ternate shape (Fig. 1A).
Nakamura et al. reported the X-ray structure of HA70 from type
C toxin, which supported the 14-mer model [6].
When PTX enters the human epithelium, it binds to carbohy-
drates of glycoproteins from epithelial cells via HA subcompo-
nents, and these bindings are thought critical to further entry of
the NTX into the bloodstream. Therefore, the mechanism of carbo-
hydrate recognition by HA subcomponents is very important to
elucidate the infection process of botulism. Several studies of the
carbohydrate-binding properties of HA subcomponents have been
done by biochemical assay and X-ray structural determination.
HA33 from type A toxin was shown to bind primarily a galactose
moiety at one carbohydrate-binding site [7]. HA33 from type C tox-
in was reported to have two carbohydrate-binding sites in different
speciﬁcities; Site-I for a sialic acid (N-acetylneuraminic acid) and
Site-II for a galactose [8–10]. HA70 has strong afﬁnity for sialylated
oligosaccharides of intestinal epithelial cell and erythrocytes, and
the X-ray structure of HA70 from type C toxin conﬁrmed the bind-
ing of a sialic acid (b-N-acetylneuraminic acid) [6].
So far, the reported X-ray structures of HA subcomponents have
contained only a monosaccharide, and no information about the
recognition mechanism of HA subcomponents for oligosaccharides
has been obtained. In order to further understand the carbohydrate
recognition mechanism of HA subcomponents, we determined fourlsevier B.V. All rights reserved.
Fig. 1. Schematic diagram of 16S toxin and the chemical structure of ligands. (A) A
hypothetical 14-mer model of the type D 16S toxin [5]. (B) Chemical structure of
a2–3-sialyllactose (3SiaLac), a2–3-sialyllactosamine (3SiaLacNAc), a2–6-sialyllac-
tose (6SiaLac), anda2–6-sialyllactosamine (3SiaLacNAc) with the names of sugar
units.
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with sialylated oligosaccharides; a2–3-sialyllactose (3SiaLac), a2–
3-sialyllactosamine (3SiaLacNAc), a2–6-sialyllactose (6SiaLac) and
a2–6-sialyllactosamine (6SiaLacNAc) (Fig. 1B), and also performed
a binding assay of HA70/C for 3SiaLacNAc and 6SiaLacNAc with a
glycoconjugate microarray.
2. Materials and methods
2.1. Protein puriﬁcation and crystallization
The expression and puriﬁcation of HA70/C have been reported
previously [6]. Brieﬂy, HA70/C was expressed as a maltose-binding
fusion protein in Escherichia coli JM109 cells, and puriﬁed by afﬁn-
ity chromatography using amylose resin (New England BioLabs
Inc.). After digestion of the fusion protein by factor Xa (New Eng-
land BioLabs Inc.), the sample was applied to a Hitrap Q HP an-
ion-exchange column (GE Healthcare). The puriﬁed protein
solution was dialyzed against PBS overnight, and concentrated to
12–20 mg/ml using an Amicon Ultra-4 30 KDa Ultracel (Merck Mil-
lipore, Billerica, MA, USA).
To improve reproducibility, screening of crystallization was per-
formed with the mosquito Crystal system (TTP LabTech Ltd. UK),
using Crystal Screen kits 1&2, PEG/Ion Screen (Hampton Research
Corp., CA, USA) and Emerald BioSystems Wizard I to IV (Emerald
BioSystems, Inc., WA, USA) by the hanging drop method in 96-well
plates (ASONE Corp., Osaka, Japan) at 293 K. After reﬁnement of the
crystallization conditions, crystals of 0.1  0.1  0.1 mm using dif-
fraction experiments were grown in a droplet containing 1.0 ll of
protein solution (18 mg/ml in PBS) and 1.0 ll of reservoir solution
(12% (v/v) 2-methyl-2,4-pentendiol, 20 mM CaCl2, 100 mM sodium
acetate (pH4.6)) against 500 ll of the reservoir solution, by thehanging drop method, at 293 K. Crystals of the complexes with
the oligosaccharide were obtained by adding 0.4 ll of 0.4 M oligo-
saccharide (3SiaLac, 3SiaLacNAc, 6SiaLac or 6SiaLacNAc; Sigma–Al-
drich) solution to the droplets of crystals for 40 h at 293 K.
2.2. X-ray structural determination
Data was collected on a PF-AR NE3A (KEK, Japan) using an ADSC
Quantum 270 CCD detector, a BL26B1 (SPring-8, Japan) using a Rig-
aku Saturn A200 CCD detector, and a Rigaku RA-Micro7HF rotating
anode (CuKa) X-ray generator with ValiMax optics (40 kV, 30 mA)
(Rigaku) using an R-AXIS VII, at 100 K. All data were processed
using the HKL2000 system [11] and/or CrystalClear system (Riga-
ku). The initial phases were determined by molecular replacement
with the program MOLREP [12] in the CCP4 program suite [13],
using the HA70/C structure (PDB code: 2ZS6) [6] as a search model.
Further model building was done with the programs Coot [14] and
X-ﬁt [15], and the structure was reﬁned by the programs Refmac5
[16] and CNS [17]. The bound oligosaccharide ligands could be lo-
cated in the (Fo–Fc) and simulated annealed omit maps (Supple-
mentary Fig. S1). The occupancy factors of 6SiaLac and
6SiaLacNAc were reﬁned, because the temperature factors were
extremely high. Water molecules were introduced if the peaks
above 3.5 r in the (Fo–Fc) electron density map were in the range
of a hydrogen bond. The data collection and structure reﬁnement
statistics are summarized in Table 1. In Ramachandran plots [18],
the number of residues in the most favored regions was deter-
mined with the program PROCHECK [19]. Figs. 2 and 3 were drawn
using the program PyMol [20].
2.3. Binding assay by glycoconjugate microarray
HA70/C labeled with Cy-3 Mono-Reactive Dye (GE Healthcare)
in the binding buffer (Rexxam Co., Ltd., Kagawa Factory, Kagawa,
Japan) (10 lg/ml) was applied to the array immobilized with a
multivalent glycan probe (3SiaLacNAc or 6SiaLacNAc-conjugated
BSA), and incubated at 298 K for 1 h, then ﬂuorescent images were
immediately acquired using an evanescent-ﬁeld activated ﬂuores-
cence scanner system, the Bio-Rex Scan 200 (Rexxam Co., Ltd.).
3SiaLacNAc-conjugated BSA was purchased (Dexyra Laboratory
Ltd.). 6SiaLacNAc-conjugated BSA was prepared by the glycoconju-
gation of BSA using N-(3-maleimidobenzoyloxy) succinimide (Nac-
alai Tesque Inc., Kyoto, Japan), with 4-aminophenyl-6SiaLacNAc,
which was converted from 4-nitrophenyl-6SiaLacNAc (Tokyo
Chemical Industry Co.) by catalytic reduction (Supplementary
Fig. S2). Fabrication of the SiaLacNAc-conjugated BSA microarray
was carried out as reported previously [21]. The performance of
microarray was validated using Wheat germ agglutinin and Sam-
bucus sieboldiana agglutinin, which have speciﬁcities to a2–3-
and a2–6-sialylated oligosaccharides, respectively (Supplementary
Fig. S3).3. Results
3.1. Protein structure and the location of carbohydrate-binding sites
The X-ray structures of the complexes of HA70/C with 3SiaLac
(HA70/C-3SiaLac), 3SiaLacNAc (HA70/C-3SiaLacNAc), 6SiaLac
(HA70/C-6SiaLac) and 6SiaLacNAc (HA70/C-6SiaLacNAc) were suc-
cessfully determined. There is one molecule of HA70/C in an asym-
metric unit, and a crystallographic 3-fold symmetry generates a
homo-trimer of HA70/C with a triangular shape (Fig. 2A). The
carbohydrate-binding sites are in the vicinity of vertices of the tri-
angle. The electron density corresponding to residues 1–14 and
185–203 was not visible, due to the highly disordered structure
Table 1
Data collection and reﬁnement statistics.
HA70/C-3SiaLac HA70/C-3SiaLacNAc HA70/C-6SiaLac HA70/C-6SiaLacNAc
Data collection
Beamline BL26B1 BL26B1 MicroMax-007HF NE3A
Temperature (K) 100 100 100 100
Wavelength (Å) 1.0 1.0 1.5418 1.0
Resolution range
(Å)
50.0–2.56
(2.60–2.56)
50.0–2.68
(2.73–2.68)
50.0–2.60
(2.69–2.60)
50.0–2.64
(2.69–2.64)
No. of measured Refs. 267,648 401,793 322,231 449,084
No. of unique Refs. 45,881 (2308) 39,818 (1961) 44,625 (4447) 42,102 (2132)
Redundancy 5.8 (5.7) 10.1 (9.3) 7.2 (7.1) 10.7 (10.3)
Completeness (%) 99.8 (100.0) 98.9 (98.2) 99.8 (100.0) 99.7 (100.0)
Mean Io/r(Io) 13.7 (3.8) 26.3 (5.0) 13.7 (4.8) 23.7 (7.9)
Rmerge⁄ (%) 8.8 (39.9) 6.6 (39.7) 8.5 (38.6) 7.5 (37.2)
Space group P63 P63 P63 P63
Cell dimensions (Å) a = b = 175.6
c = 80.8
a = b = 176.0
c = 80.8
a = b = 177.3
c = 80.8
a = b = 176.0
c = 80.6
Reﬁnement
Resolution range (Å) 25.74–2.56
(2.72 – 2.56)
29.20–2.68
(2.85–2.68)
34.67–2.60
(2.76–2.60)
33.26–2.64
(2.81–2.64)
No. of Refs. 44,727 (7024) 39,051 (6208) 44,622 (7369) 40,313 (6375)
Completeness (%) 97.3 (92.2) 97.0 (92.8) 99.7 (100.0) 95.8 (91.2)
Rfactor (%) 19.1 (27.0) 18.5 (26.8) 19.7 (29.7) 19.6 (27.6)
Rfree (%) 21.9 (30.6) 21.3 (31.4) 23.5 (33.1) 22.0 (32.1)
RMSD bond lengths (Å) 0.006 0.006 0.006 0.006
RMSD bond angles () 1.4 1.4 1.4 1.4
Ramachandran plot
Most favored region(%) 84.7 83.4 85.8 87.0
Additional allowed region (%) 15.3 16.6 14.2 13.0
B-factor (Å2)/Occupancy
Protein 51.2/1.0 54.4/1.0 51.5/1.0 51.1/1.0
Ligand 63.9/1.0 67.4/1.0 63.9/0.79 70.8/0.86
Solvent 56.6/1.0 58.1/1.0 56.2/1.0 53.9/1.0
PDB code 4EN6 4EN7 4EN8 4EN9
Values in parentheses are of the high-resolution bin.
* Rmerge = RhRi [|Ii(h)  <I(h)>|/RhRiIi(h)], where Ii is the ith measurement and <I(h)> is the weighted mean of all measurements of I(h).
Fig. 2. Structure of HA70/C with the bound ligands. (A) Homo-trimer of HA70/C with the bound ligand in the space-ﬁlling mode with gray carbon (3SiaLac) and cyan carbon
(6SiaLac). HA22–23/C, and domain-I, -II, and -III of HA55/C are in blue, magenta, yellow and green, respectively. Symmetry-operated molecules are in light colors. (B) A close-
up view of the carbohydrate-binding site with the bound ligand shown as a stick model. The b-strands of domain-II and -III are labeled. The b2–7 sheet of domain-II and b1–6
sheet of domain-III forming a large b-sheet are in dark colors. The b6–7 loop of domain-II, and the b1–2 loop and b2 of domain-III are in red, forming the concave surface for an
oligosaccharide ligand to bind.
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crystallization process, giving HA22–23/C (residues 1–184) and
HA55/C (204–623) fragments, as reported previously [6]. HA55/C
can be divided into three domains, domain-I (204–372), -II (373–
496) and -III (497–623). HA22–23/C (blue) and domain-I of
HA55/C (magenta) are similar in structure, having an elongated
b-sheet and embedded a-helices. They are involved in inter-molec-
ular interactions between b-strands to form the core b-barrel of ahomo-trimer. Domain-II (yellow) and domain-III (green) of
HA55/C adopt a b-sandwich structure formed by two b-sheets con-
sisting of four b-strands (b2, b9, b4 and b7; b2–7 sheet) and ﬁve b-
strands (b1, b3, b8, b5 and b6; b1–6 sheet), as shown in Fig. 2B. The
b2–7 sheet of domain-II and b1–6 sheet of domain-III are con-
nected between b7 and b1, forming a large b-sheet of nine b-
strands by two domains. The b1–6 sheet of domain-II and b2–7
sheet of domain-III are located on the same side of the large b-
Fig. 3. Stereo views of interactions between the protein and ligands. (A)The bound 3SiaLac between domain-II (yellow) and -III (green) is shown with hydrogen bonds by
dotted lines. (B) The bound 6SiaLac is shown.
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a ligand to bind is formed by the loop region between b6 and b7
(b6–7 loop) of domain-II, the loop region between b1 and b2
(b1–2 loop) of domain-III, and b2 of domain-III, as shown in red
(Fig. 2B).
3.2. Interactions between proteins and ligands
Since the bound 3SiaLac and 3SiaLacNAc, or 6SiaLac and
6SiaLacNAc have the same molecular conformation forming almost
equivalent interactions with proteins, the structural description
here concentrates on the two carbohydrate-binding sites of 3SiaLac
and 6SiaLac.
The structure of the carbohydrate-binding site with the bound
3SiaLac is shown in Fig. 3A. The bound 3SiaLac adopts an extended
structure with the glycoside linkages as listed in Table 2. An
N-acetylneuraminic acid moiety (Sia) at the non-reducing end
has a 2C5 conformation, and binds to the concave surface between
domain-II and -III. The carboxyl group at the 1-position forms
hydrogen bonds with Thr524 (N and OG), an N-acetyl group at
the 5-position with Tyr522 (O) and Asn514 (ND), and a glycerolpart at the 6-position with Asp513 (OD) and Arg525 (NH). A galact-
ose moiety (Gal) with a 4C1 conformation forms hydrogen bonds
with amino acid residues of domain-II; namely O4 – Arg460(NH),
O4 – Asp462(OD) and O3 (glycoside oxygen) – Arg460(NH). A
glucose moiety (Glc) with a 4C1 conformation locates in the solvent
region, being free from the proteins including neighboring
molecules in the crystal, without any direct interactions.
The structure of the carbohydrate-binding site with the bound
6SiaLac is shown in Fig. 3B, in which the bound 6SiaLac has a bent
structure. The hydrogen bond interactions between Sia and the
protein are almost the same as in HA70/C-3SiaLac, and an addi-
tional hydrogen bond between a glycerol part and Asp513 is found,
because Sia moves to the domain-III by 0.5 Å relative to 3SiaLac
(Fig. 2B). Gal does not have any direct interactions with amino acid
residues, and Glc possibly forms hydrogen bonds with Arg460 (NH)
via O2 and O4 (glycoside oxygen).
3.3. Binding assay of HA70/C
The results of the binding assay of HA70/C for 3SiaLacNAc- and
6SiaLacNAc-conjugated BSA are shown in Fig. 4A. Binding of HA70/
Table 2
Glycoside linkage conformations of the bound sialylated oligosaccharide ligands.
Protein PDBID Sia-Gal Gal-Glc A.A.*
3SiaLac (3SiaLacNAc)
O6-C2-O3-C3 C2-O3-C3-C4 O5-C1-O4-C4 C1-O4-C4-C5
/ w / w
Anti-periplanar conformation
HA70/C-3SiaLac 55 81 59 118 Thr
-3SiaLacNAc 53 77 73 112 Thr
Hemagglutinin 3HTT 55 102 70 104 Thr
Sigma-1 3S6X 67 107 100 162 Arg
Synclinal conformation
Sialoadhesin 1QFO 48 102 80 130 Arg
Hemagglutinin 1HGG 58 116 67 133 Ser
IG-like lectin-5 2ZG3 57 102 55 105 Arg
Leukoagglutinin 1DBN 49 122 95 107 Lys
Galectin-8 3AP7 58 127 66 104 Arg
Galectin-9 3NV4 47 116 66 102 Arg
6SiaLac (6SiaLacNAc)
O6-C2-O6-C6 C2-O6-C6-C5 O6-C6-C5-O5 O5-C1-O4-C4 C1-O4-C4-C5
/ w x / w
Anti-periplanar conformation
HA70/C-6SiaLac 40 120 42 179 160 Thr
–6SiaLacNAc 47 129 59 170 169 Thr
Synclinal conformation
Lectin 2DSO 60 151 71 62 127 Ser
Sigma-1 3S6Y 66 166 58 30 151 Arg
* A.A means the amino acid residue interacting with the carboxyl group of Sia.
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in a concentration-dependent manner (Fig. 4B), but was very weak
on the spots of 6SiaLacNAc-conjugated BSA, indicating that HA70/C
has higher afﬁnity for 3SiaLacNAc- than 6SiaLacNAc-conjugated
BSA.
4. Discussion
Both3SiaLac (3SiaLacNAc) and 6SiaLac (6SiaLacNAc) were found
to bind to HA70/C in crystal structures, and each Sia moiety was
recognized by many hydrogen bonds in a similar manner, suggest-
ing that HA70/C can recognize both a2–3- and a2–6-sialylated
oligosaccharides. In the previously reported structure [6], b-N-
acetylneuraminic acid was found in the almost equivalent position,
but its orientation and interactions with the protein are quite
different from those in this study (Supplementary Fig. S4). This is
because the position of a carboxyl group depending on a- or b-ano-
mer extensively affects the binding mode of each Sia moiety.
The Sia-Gal glycoside linkage of the bound 3SiaLac adopts a
stable anti-periplanar conformation with respect to a carboxyl
group of Sia and Gal (Supplementary Fig. S5A). This Sia-Gal con-
formation was found in PDB, 3HTT (inﬂuenza A virus hemagglu-
tinin) [22]and 3S6X (reovirus attachment protein Sigma-1) [23].
The synclinal conformation was also found as listed in Table 2.
The synclinal conformation is unfavorable in steric considerations,
but favorable in exo-anomeric effect, where lone-pair electrons of
O6 (Sia) and O3 (glycoside oxygen) face in opposite directions to
each other [24]. In solution, 3SiaLac is expected to exist in these
two conformers with almost equivalent structural energies. The
proteins recognize the anti-periplanar or synclinal conformation
depending on their carbohydrate-binding site structures. HA70/
C strictly recognizes Sia-Gal moieties with the anti-periplanar
conformation, where Sia deeply enters the concave surface of
the protein (binding pocket) with many hydrogen bonds, exclud-
ing the binding of the synclinal conformer to cause a collision
with amino acid residues (Arg460-Asp462). In most cases, posi-
tively charged amino acid residues (Arg and Lys) recognize the
carboxyl group of Sia through salt-bridges. In HA70/C, Thr524
forms hydrogen bonds with the carboxyl group via OG and N
atoms, in a manner similar to that in 3HTT and 1HGG (inﬂuenzaA virus hemagglutinin) [25], where the carboxyl group was rec-
ognized by hydrogen bonds of Thr (OG), and Ser (OG) with the
neighboring residue (N), respectively (Table 2). Thus, it is thought
that there are two different ways in which the carboxyl group of
Sia is recognized via Arg/Lys and Thr/Ser, however the correlation
between this difference and the carbohydrate-binding site struc-
ture is unclear. The Gal-Glc glycoside linkage adopts a stable con-
formation in the exo-anomeric effect, which is found in all of
structures in PDB (Table 2).
The / of the Sia-Gal conformation of the bound 6SiaLac is the
same as that of 3SiaLac, and x adopts the most stable gauche-trans
conformation for Gal with an axial hydroxyl group at the 4-posi-
tion (Supplementary Fig. S5B). The Gal-Glc glycoside linkage of
6SiaLac adopts an unfavorable conformation in the exo-anomeric
effect, where lone-pair electrons of O5 (Gal) and O4 (glycoside oxy-
gen) are close to each other, but it gives possible hydrogen bonds
between Glc and Arg460. Two X-ray structures containing 6SiaLac
were found in PDB, 2DS0 (earthworm lectin) [26] and 3S6Y
(reovirus attachment protein Sigma-1) [24], where the Sia-Gal
and Gal-Glc glycoside linkages adopt the synclinal/gauche-trans
conformation and a stable conformation in the exo-anomeric
effect, respectively, resulting in favorable interactions with the
proteins (Table 2).
The reﬁned occupancy factors of the ligands suggest that the
complexes with 3SiaLac/3SiaLacNAc are stable relative to the com-
plexes with 6SiaLac/6SiaLacNAc, though the number of protein–li-
gand hydrogen bonds is almost same to each other. Gal of 3SiaLac/
3SiaLacNAc is strictly recognized by hydrogen bonds between its
axial hydroxyl group at the 4-position and Arg460/Asp462. While
Glc of 6SiaLac and GlcNAc of 6SiaLacNAc have high temperature
factors of 83.0 Å2 and 87.7 Å2, respectively, and the hydrogen
bonds between the protein and Glc/GlcNAc should be partially
formed. Thus, the complexes with 3SiaLac/3SiaLacNAc are thought
to be stabilized by the efﬁcient interactions between Sia-Gal and
the proteins, more than the complexes with 6SiaLac/6SiaLacNAc.
Most N-glycan-type oligosaccharides have a b1–2 linked mannose
(Man) with Glc. Man can be attached to the bound 3SiaLac in
Fig. 3A by a b1–2 linkage without any steric hindrance, because
Glc is completely free from the protein, indicating that HA70/C
recognizes a2–3-sialylated oligosaccharides in the same manner
Fig. 4. Binding assay of HA against SiaLacNAc-BSA. (A) Varying concentrations of
SiaLacNAc-BSA (65–1000 lg/ml) were spotted on epoxyactivated glass slides.
Ligand coupling was measured using 10 lg/ml of Cy3-labeled HA70/C. The net
intensity value for each spot was determined as the signal intensity minus the
background value, and data are the average of three columns. The average values of
net intensities are also listed with estimated standard deviations. (B) Data are
plotted with error bars.
S. Yamashita et al. / FEBS Letters 586 (2012) 2404–2410 2409as found in the presented structure. In contrast, Man cannot be
attached to the bound 6SiaLac with a bent structure in Fig. 3B, be-
cause there is no space for Man; the distance between Glc and
Asn320 is only 4.2 Å. When an a2–6-sialylated oligosaccharide
binds to HA70/C in vivo, the Gal-Glc conformation should be differ-
ent from that found in the presented structure, without interac-
tions between Glc and the protein, leading to less protein–ligand
interaction. The binding assay also showed higher afﬁnity of
HA70/C for 3SiaLacNAc-conjugated BSA. HA70 should bind to the
3SiaLacNAc/6SiaLacNAc-conjugated BSA in a similar manner to
glycoproteins with N-glycan-type oligosaccharides in vivo.
6SiaLacNAc linked to the Cys residues of BSA could not adopt the
conformation found in a crystal structure, which causes a collision
with Asn320. Therefore, HA70/C is expected to have higher
afﬁnity for a2–3-sialylated oligosaccharides than a2–6-sialylated
oligosaccharides.
5. PDB accession number
Coordinates and structure factors of HA70/C-3SiaLac, HA70/C-
3SiaLacNAc, HA70/C-6SiaLac and HA70/C-6SiaLacNAc have been
deposited in the Protein Data Bank under accession codes 4EN6,
4EN7, 4EN8 and 4EN9, respectively.Acknowledgements
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